About VIP - Immune Response / Repair

VIP (Vasoactive Intestinal Peptide) stack is typically focused on calming severe systemic inflammation, resetting immune regulation, and addressing neuroinflammation or CIRS (mold toxicity). It's commonly paired with gut- and immune-support peptides like BPC-157 or KPV to speed up tissue repair and balance the immune system.

WHAT THE RESEARCH SHOWS

Research on VIP (Vasoactive Intestinal Peptide) a 28-amino acid neuropeptide naturally produced in the gut, brain, and immune tissues—focuses heavily on inflammation, blood flow, and mucosal defense:
* CIRS & Biotoxin Illness: VIP is best known in clinical research through the Shoemaker Protocol for treating Chronic Inflammatory Response Syndrome (CIRS) and mold toxicity. Studies show intranasal VIP helps reset severe neuroinflammation, lowers inflammatory markers (like TGF-beta 1 and C4a), and restores dysregulated regulatory neuropeptides.
* Immune & Cytokine Regulation: It acts as a potent anti-inflammatory agent, downregulating pro-inflammatory cytokines (like TNF-alpha and IL-6) while boosting anti-inflammatory IL-10 and supporting regulatory T-cells (Tregs).
* Cardiopulmonary & Vasodilation: As the name suggests, VIP causes smooth muscle relaxation. Research demonstrates its ability to lower pulmonary artery pressure, improve arterial blood flow, and open up constricted airways (bronchodilation).
* Gut Barrier & Mucosal Health: In the digestive tract, VIP regulates mucosal secretions, promotes healthy gut motility, and helps protect the intestinal lining against local autoimmune inflammation. Because VIP degrades quickly in the digestive tract, research protocols predominantly use it as an intranasal spray (especially for CIRS and neurological recovery) or subQ injection.

Lyophilised powder